- Market Capitalization, $K 1,061,980
- Shares Outstanding, K 32,084
- Annual Sales, $ 0 K
- Annual Income, $ -88,960 K
- 60-Month Beta 1.83
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 5.35
|Period||Period Low||Period High||Performance|
| || |
+4.60 (+16.14%)since 10/15/19
| || |
-0.34 (-1.02%)since 08/15/19
| || |
+16.58 (+100.36%)since 11/15/18
Zacks.com featured highlights include: Odonate Therapeutics, Novavax, Beazer Homes USA and NVIDIA
Odonate Therapeutics, Inc. (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Studies have shown that a majority of successful stocks see acceleration in earnings before an uptick in the stock price.
Jazz Pharmaceuticals (JAZZ) reports encouraging first-quarter 2019 earnings and revenues and maintains its guidance for 2019.
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Newmont Mining Corporation (NYSE:NEM),...
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Omnicom Group Inc. (NYSE:OMC),...
|Odonate Therapeutics Inc|
|Micro-Cap Ishares ETF|
|US Innovative Healthcare Ishares Evolved ETF|
|Russell 2000 Growth Ishares ETF|
|SPDR Small Cap Portfolio ETF|
|Russell 2000 Growth Vanguard|